Black Rock Inc. Dyne Therapeutics, Inc. Transaction History
Black Rock Inc.
- $4.23 Trillion
- Q1 2024
A detailed history of Black Rock Inc. transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 5,390,042 shares of DYN stock, worth $172 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,390,042
Previous 3,788,682
42.27%
Holding current value
$172 Million
Previous $50.4 Million
203.68%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding DYN
# of Institutions
176Shares Held
87.1MCall Options Held
130KPut Options Held
209K-
Atlas Venture Life Science Advisors, LLC8.02MShares$256 Million28.49% of portfolio
-
Fcpm Iii Services B.V. Naarden, P77.85MShares$250 Million31.49% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.56MShares$145 Million4.27% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il4.25MShares$136 Million0.02% of portfolio
-
State Street Corp Boston, MA4.19MShares$134 Million0.01% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $1.65B
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...